Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Take Tell Us What YOU Think! Take The Body's Visitor Survey!
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

CDC's Clinical Studies of Daily Oral Tenofovir for HIV Prevention

June 2005

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

Table of Contents

Advertisement

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

 
See Also
Two New Studies Support Use of PrEP for HIV Prevention Among Heterosexual Men and Women
CDC Statement: CDC Trial and Another Major Study Find PrEP Can Reduce Risk of HIV Infection Among Heterosexuals
U. Washington Statement: Pivotal Study Finds That HIV Medications Are Highly Effective as Prophylaxis Against HIV Infection in Men and Women in Africa
iPrEx Statement: Two Major Studies Prove HIV Pre-Exposure Prophylaxis (PrEP) Works in in Heterosexual Women and Men; Build on iPrEx Data Showing PrEP Reduces HIV Infections in Men Who Have Sex With Men
More on HIV Medications for HIV Prevention

 

Advertisement